
Chinese General Practice ›› 2024, Vol. 27 ›› Issue (03): 280-285.DOI: 10.12114/j.issn.1007-9572.2023.0306
Special Issue: 中医最新文章合辑; 女性健康最新文章合辑
• Original Research • Previous Articles Next Articles
Received:2023-06-01
Revised:2023-08-02
Published:2024-01-20
Online:2023-10-23
Contact:
BAI Wenpei
通讯作者:
白文佩
作者简介:基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0306
| 体检项目 | 基线 | 3年后 | t配对值 | P值 |
|---|---|---|---|---|
| 腰围(cm) | 76.31±7.25 | 77.91±7.62 | -5.120 | <0.001 |
| BMI(kg/m2) | 23.2±3.0 | 23.3±3.2 | -0.297 | 0.767 |
| UA(μmol/L) | 261.71±48.84 | 279.91±58.11 | -8.916 | <0.001 |
| TC(mmol/L) | 4.76±0.59 | 5.01±0.76 | -7.885 | <0.001 |
| TG(mmol/L) | 1.02±0.38 | 1.22±0.71 | -6.054 | <0.001 |
| FBG(mmol/L) | 5.24±0.56 | 5.16±0.65 | 3.820 | <0.001 |
| HDL-C(mmol/L) | 1.49±0.28 | 1.46±0.30 | 0.306 | 0.760 |
| LDL-C(mmol/L) | 2.78±0.58 | 2.87±0.68 | -2.072 | 0.039 |
Table 1 Follow-up results of research subjects
| 体检项目 | 基线 | 3年后 | t配对值 | P值 |
|---|---|---|---|---|
| 腰围(cm) | 76.31±7.25 | 77.91±7.62 | -5.120 | <0.001 |
| BMI(kg/m2) | 23.2±3.0 | 23.3±3.2 | -0.297 | 0.767 |
| UA(μmol/L) | 261.71±48.84 | 279.91±58.11 | -8.916 | <0.001 |
| TC(mmol/L) | 4.76±0.59 | 5.01±0.76 | -7.885 | <0.001 |
| TG(mmol/L) | 1.02±0.38 | 1.22±0.71 | -6.054 | <0.001 |
| FBG(mmol/L) | 5.24±0.56 | 5.16±0.65 | 3.820 | <0.001 |
| HDL-C(mmol/L) | 1.49±0.28 | 1.46±0.30 | 0.306 | 0.760 |
| LDL-C(mmol/L) | 2.78±0.58 | 2.87±0.68 | -2.072 | 0.039 |
| 组别 | 人数 | 腰围(cm) | BMI(kg/m2) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 基线 | 3年后 | t配对值 | P值 | 基线 | 3年后 | t配对值 | P值 | ||
| 未绝经组 | 176 | 75.76±6.78 | 77.62±7.47 | -3.806 | <0.001 | 23.0±2.8 | 23.2±3.1 | -0.755 | 0.451 |
| 绝经组 | 291 | 76.66±7.53 | 78.09±7.72 | -3.682 | <0.001 | 23.3±3.2 | 23.3±3.2 | 0.357 | 0.722 |
| t值 | 1.189 | 0.574 | 0.921 | 0.409 | |||||
| P值 | 0.235 | 0.566 | 0.358 | 0.683 | |||||
Table 2 Comparison of waist circumference and BMI between the two groups
| 组别 | 人数 | 腰围(cm) | BMI(kg/m2) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 基线 | 3年后 | t配对值 | P值 | 基线 | 3年后 | t配对值 | P值 | ||
| 未绝经组 | 176 | 75.76±6.78 | 77.62±7.47 | -3.806 | <0.001 | 23.0±2.8 | 23.2±3.1 | -0.755 | 0.451 |
| 绝经组 | 291 | 76.66±7.53 | 78.09±7.72 | -3.682 | <0.001 | 23.3±3.2 | 23.3±3.2 | 0.357 | 0.722 |
| t值 | 1.189 | 0.574 | 0.921 | 0.409 | |||||
| P值 | 0.235 | 0.566 | 0.358 | 0.683 | |||||
| 组别 | 人数 | UA(μmol/L) | TC(mmol/L) | TG(mmol/L) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 基线 | 3年后 | t配对值 | P值 | 基线 | 3年后 | t配对值 | P值 | 基线 | 3年后 | t配对值 | P值 | ||
| 未绝经组 | 176 | 260.09±50.07 | 268.69±58.34 | -2.897 | 0.004 | 4.74±0.58 | 4.85±0.66 | -2.932 | 0.004 | 1.02±0.39 | 1.19±0.55 | -4.836 | <0.001 |
| 绝经组 | 291 | 262.69±48.13 | 286.69±57.00 | -8.935 | <0.001 | 4.77±0.60 | 5.10±0.79 | -7.543 | <0.001 | 1.02±0.38 | 1.25±0.79 | -4.577 | <0.001 |
| t值 | 0.556 | 3.278 | 0.573 | 3.521 | 0.005 | 0.804 | |||||||
| P值 | 0.578 | 0.001 | 0.567 | <0.001 | 0.996 | 0.422 | |||||||
| 组别 | FBG(mmol/L) | HDL-C(mmol/L) | LDL-C(mmol/L) | ||||||||||
| 基线 | 3年后 | t配对值 | P值 | 基线 | 3年后 | t配对值 | P值 | 基线 | 3年后 | t配对值 | P值 | ||
| 未绝经组 | 5.20±0.57 | 5.15±0.65 | 1.213 | 0.227 | 1.47±0.31 | 1.45±0.32 | 0.173 | 0.863 | 2.77±0.58 | 2.76±0.58 | 0.435 | 0.664 | |
| 绝经组 | 5.26±0.55 | 5.17±0.66 | 1.803 | 0.072 | 1.50±0.27 | 1.47±0.29 | 0.259 | 0.796 | 2.80±0.58 | 2.95±0.73 | -2.881 | 0.005 | |
| t值 | 1.132 | 0.283 | 0.787 | 0.740 | 0.423 | 2.823 | |||||||
| P值 | 0.258 | 0.777 | 0.432 | 0.460 | 0.672 | 0.005 | |||||||
Table 3 Comparison of laboratory examination indexes between the two groups
| 组别 | 人数 | UA(μmol/L) | TC(mmol/L) | TG(mmol/L) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 基线 | 3年后 | t配对值 | P值 | 基线 | 3年后 | t配对值 | P值 | 基线 | 3年后 | t配对值 | P值 | ||
| 未绝经组 | 176 | 260.09±50.07 | 268.69±58.34 | -2.897 | 0.004 | 4.74±0.58 | 4.85±0.66 | -2.932 | 0.004 | 1.02±0.39 | 1.19±0.55 | -4.836 | <0.001 |
| 绝经组 | 291 | 262.69±48.13 | 286.69±57.00 | -8.935 | <0.001 | 4.77±0.60 | 5.10±0.79 | -7.543 | <0.001 | 1.02±0.38 | 1.25±0.79 | -4.577 | <0.001 |
| t值 | 0.556 | 3.278 | 0.573 | 3.521 | 0.005 | 0.804 | |||||||
| P值 | 0.578 | 0.001 | 0.567 | <0.001 | 0.996 | 0.422 | |||||||
| 组别 | FBG(mmol/L) | HDL-C(mmol/L) | LDL-C(mmol/L) | ||||||||||
| 基线 | 3年后 | t配对值 | P值 | 基线 | 3年后 | t配对值 | P值 | 基线 | 3年后 | t配对值 | P值 | ||
| 未绝经组 | 5.20±0.57 | 5.15±0.65 | 1.213 | 0.227 | 1.47±0.31 | 1.45±0.32 | 0.173 | 0.863 | 2.77±0.58 | 2.76±0.58 | 0.435 | 0.664 | |
| 绝经组 | 5.26±0.55 | 5.17±0.66 | 1.803 | 0.072 | 1.50±0.27 | 1.47±0.29 | 0.259 | 0.796 | 2.80±0.58 | 2.95±0.73 | -2.881 | 0.005 | |
| t值 | 1.132 | 0.283 | 0.787 | 0.740 | 0.423 | 2.823 | |||||||
| P值 | 0.258 | 0.777 | 0.432 | 0.460 | 0.672 | 0.005 | |||||||
| 组别 | 人数 | CIMT增厚 | 高血压 |
|---|---|---|---|
| 未绝经组 | 176 | 11(6.3) | 9(5.1) |
| 绝经组 | 291 | 20(6.9) | 32(11.0) |
| χ2值 | 0.069 | 4.739 | |
| P值 | 0.793 | 0.029 |
Table 4 Comparison of the incidence of increased CIMT and hypertension between the two groups
| 组别 | 人数 | CIMT增厚 | 高血压 |
|---|---|---|---|
| 未绝经组 | 176 | 11(6.3) | 9(5.1) |
| 绝经组 | 291 | 20(6.9) | 32(11.0) |
| χ2值 | 0.069 | 4.739 | |
| P值 | 0.793 | 0.029 |
| 自变量 | CIMT增厚 | 高血压 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| β | SE | Wald χ2值 | P值 | OR(95%CI) | β | SE | Wald χ2值 | P值 | OR(95%CI) | |
| 绝经 | 0.258 | 0.441 | 0.343 | 0.558 | 1.295(0.545~3.075) | 0.271 | 0.360 | 0.564 | 0.452 | 1.311(0.647~2.654) |
| 年龄≥50岁 | 0.906 | 0.438 | 4.285 | 0.038 | 2.475(1.049~5.838) | 0.525 | 0.350 | 2.257 | 0.133 | 1.691(0.852~3.355) |
Table 5 Multivariate Logistic regression analysis of the effect of menopause and age on the incidence of increased CIMT and hypertension in middle-aged women
| 自变量 | CIMT增厚 | 高血压 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| β | SE | Wald χ2值 | P值 | OR(95%CI) | β | SE | Wald χ2值 | P值 | OR(95%CI) | |
| 绝经 | 0.258 | 0.441 | 0.343 | 0.558 | 1.295(0.545~3.075) | 0.271 | 0.360 | 0.564 | 0.452 | 1.311(0.647~2.654) |
| 年龄≥50岁 | 0.906 | 0.438 | 4.285 | 0.038 | 2.475(1.049~5.838) | 0.525 | 0.350 | 2.257 | 0.133 | 1.691(0.852~3.355) |
| [1] |
|
| [2] |
中华医学会妇产科学分会绝经学组. 中国绝经管理与绝经激素治疗指南2023版[J]. 中华妇产科杂志,2023,58(1):4-21. DOI:10.3760/cma.j.cn112141-20221118-00706.
|
| [3] |
|
| [4] |
中华医学会心血管病学分会介入心脏病学组,中华医学会心血管病学分会动脉粥样硬化与冠心病学组,中国医师协会心血管内科医师分会血栓防治专业委员会,等. 稳定性冠心病诊断与治疗指南[J]. 中华心血管病杂志,2018,46(9):680-694. DOI:10.3760/cma.j.issn.0253-3758.2018.09.004.
|
| [5] |
陈中国,朱晓丽,万宇婷,等. 颈动脉内膜中层厚度与冠心病的相关性分析[J]. 中华介入放射学电子杂志,2019,7(1):31-34. DOI:10.3877/cma.j.issn.2095-5782.2019.01.006.
|
| [6] |
罗兰,牛敏,高政南. 中心性肥胖及血糖异常与颈动脉内膜-中层厚度的相关性[J]. 中华糖尿病杂志,2019,11(3):196-200. DOI:10.3760/cma.j.issn.1674-5809.2019.03.007.
|
| [7] |
陈波,杨万勇,石新年,等. Hcy、Cyst C、RPB4和颈动脉内膜中层厚度检测在健康体检中预防作用的研讨[J]. 国际医药卫生导报,2020,26(3):314-317. DOI:10.3760/cma.j.issn.1007-1245.2020.03.006.
|
| [8] |
国家卫生健康委员会疾病预防控制局,国家心血管病中心,中国医学科学院阜外医院,等. 中国高血压健康管理规范(2019)[J]. 中华心血管病杂志,2020,48(1):10-46. DOI:10.3760/cma.j.issn.0253-3758.2020.01.004.
|
| [9] | |
| [10] |
中华医学会妇产科学分会绝经学组. 围绝经期异常子宫出血诊断和治疗专家共识[J]. 协和医学杂志,2018,9(4):313-319. DOI:10.3969/j.issn.1674-9081.2018.04.006.
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
张莹,杜鑫,李劼,等. 血清超敏C反应蛋白水平与颈动脉内膜中层厚度的相关性分析[J]. 中国综合临床,2021,37(1):26-30. DOI:10.3760/cma.j.cn101721-20200712-00010.
|
| [1] | YU Haiyan, XIANG Tong, GAO Wenjuan, WU Hao. Research and Application of Digital Health Technologies in Multimorbidity Management [J]. Chinese General Practice, 2026, 29(21): 2933-2937. |
| [2] | CHEN Dian, LONG Huanyu, CHU Lanhe, JIANG Yixia, GUO Wanjin, NIU Yang, CHEN Yahong. Interpretation of Global Strategy for the Diagnosis, Treatment, Management and Prevention of Chronic Obstructive Pulmonary Disease 2026 Report [J]. Chinese General Practice, 2026, 29(21): 2913-2932. |
| [3] | LI Wenping, CHEN Jianhua, XU Jiapei, JIN Xue, PAN Zihan, CHI Chunhua. A Scoping Review on the Empowerment of Community Elderly Health Services by Digital-Intelligent Health Management Platforms [J]. Chinese General Practice, 2026, 29(21): 2938-2949. |
| [4] | CHAI Zhihao, ZHANG Weisen, LUO Jiaoling, ZHU Feng, ZHU Tong, JIN Yali, PAN Jing, LU Yingjun, JIANG Chaoqiang. The Mediation Effect of Socioeconomic Status in Childhood Parental Literacy and Cognitive Function in Middle-aged and Older People: Based on Guangzhou Biobank Cohort Study [J]. Chinese General Practice, 2026, 29(21): 2959-2966. |
| [5] | HAN Congcong, QIU Xinyu, SHAN Chunfang, SONG Ning, CHEN Qingjie, MULADILI· Abudureheman, LI Xiaomei, YANG Yining, ZHAO Qian. Impact of Metabolic Obesity Phenotype on Long-term Prognosis after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome [J]. Chinese General Practice, 2026, 29(21): 2950-2958. |
| [6] | AN Yanhong, WANG Shidong, LI Xiaoran, GUO Jiayang, WANG Zhe, SHA Peilin, MENG Yijun, LI Xiaoxuan, SHI Xue, YU Zexing, XIAO Yonghua. Study on Risk Factors and Nomogram Prediction Model for Diabetic Kidney Disease: Based on Contrast-enhanced Ultrasound Technology [J]. Chinese General Practice, 2026, 29(21): 2995-3003. |
| [7] | ZHANG Ke, ZENG Xianchang, ZOLZAYA Enkhzaya, ZHU Yelin, HUANG Yiwen, LIU Zhenxiu, TAO Feng. Effect of Xiere Xingpi Yin on Eating Behaviors and Weight-related Outcomes in Patients with Obesity: a Randomized Controlled Trial [J]. Chinese General Practice, 2026, 29(20): 2759-2765. |
| [8] | WU Yixuan, XIAO Liangman, LIU Xin, YAN Ziqi, WANG Yuting, LIN Shumin, ZHUANG Lixing. Analysis of the Disease Burden of Parkinson's Disease in China and Globally from 1990 to 2021 and Prediction of Future Trends [J]. Chinese General Practice, 2026, 29(20): 2895-2902. |
| [9] | WU Zhen, XI Yaqi, HU Linlin. Characteristics of Policy Instrument Selection and Combination for Weight Management in China: a Content Analysis of National Policy Documents (2016-2025) [J]. Chinese General Practice, 2026, 29(20): 2766-2774. |
| [10] | REYILAI· Maimaiti, ZHOU Yiran, WU Yun, LIU Zhencheng, LU Yaoqin, WU Haiyan. Association between Novel Obesity Indicators and Cardiovascular Disease Risk in Hypertensive Patients [J]. Chinese General Practice, 2026, 29(20): 2836-2845. |
| [11] | CHEN Xiangyang, HUANG Hongmei, LI Sheyu. Prevention and Management of Adult Obesity: Progress and Trends from Six Keywords in 2025 [J]. Chinese General Practice, 2026, 29(20): 2753-2758. |
| [12] | ZHANG Zeyu, LI Chunhui. Ischemic Heart Disease Burden Attributable to Second-hand Smoke in China from 1990 to 2021 [J]. Chinese General Practice, 2026, 29(20): 2903-2912. |
| [13] | CHENG Yu, HAN Shiyao, SUN Ping, XIANG Juan, YANG Hui, LI Dongze, ZHENG Li, LIAO Xiaoyang. Analysis of Socioeconomic and Demographic Challenges in Chronic Disease Management [J]. Chinese General Practice, 2026, 29(20): 2800-2807. |
| [14] | YANG Xiaofeng, LI Xianwen, WU Yanfeng, ZHANG Qian, CHEN Juan, ZHAO Fengjiao. Association of Serum Vascular Endothelial Cadherin Levels with the Risk of Post-stroke Cognitive Impairment in Patients with Acute Ischemic Stroke [J]. Chinese General Practice, 2026, 29(20): 2867-2873. |
| [15] | LI Feng, HU Changhao, LUO Xu. Progress in the Study of Influencing Factors and Intervention Strategies of Mental Health in Elderly Patients with Multiple Chronic Conditions [J]. Chinese General Practice, 2026, 29(20): 2816-2828. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||